MGF

Compound Overview

Research Use Only. Not for Human Consumption.

MGF 2mg is supplied by Nexus as an unpegylated mechano growth factor peptide for controlled in-vitro research workflows. The provided chemistry record classifies MGF as an IGF-1Ec / mechano growth factor peptide and describes it as an unpegylated mechano growth factor E-peptide, commonly represented as a 24-amino-acid IGF-1 splice-variant-derived peptide.

This page is intentionally limited to the supplied Nexus product record and the provided MGF research data. The source data supports the product name, SKU, available research size, classification, sequence, sequence display, molecular formula, molecular weight, physical form, storage guidance, and intended-use restriction. It does not provide a confirmed CAS number, purity value, batch number, HPLC retention time, observed MS value, COA release date, salt form, counter-ion, reconstitution solvent, or post-reconstitution stability interval. Those values are not inferred.

The source record also makes an important identity distinction: this product is unpegylated MGF. It should not inherit PEG-MGF molecular-weight data or be treated as analytically interchangeable with PEG-MGF. PEG-MGF contains a polymer modification and is described in the source data as having variable mass, while this MGF record lists the unpegylated peptide formula and molecular weight shown below.

• Product: MGF
• SKU: FM2
• Available Research Size: 2mg
• Catalog Category: Growth Hormone Secretagogues
• Classification: IGF-1Ec / mechano growth factor peptide
• Sequence: YQPPSTNKNTKSQRRKGSTFEEHK
• Physical Form: Lyophilized powder
• Use: For in-vitro research use only. Not for human consumption.

Research Background & Published Literature

The provided research background identifies MGF as the unpegylated mechano growth factor peptide SKU and notes that vendor records typically define it as a short half-life unpegylated peptide. That background is included here only as research-context identity language. It is not a human-use claim, veterinary-use claim, dosing statement, therapeutic statement, or disease-related statement.

The supplied record does not include PubMed identifiers, paper titles, authors, journal names, experimental models, assay conditions, concentration ranges, biological outcome data, or citation-level summaries. Because those details are not present, this generated description does not add unsupported literature claims or infer mechanistic findings from adjacent compounds.

Two source references are included in the MGF research record for identity and general compound-profile context:

Researchers evaluating MGF should use these references and current lot-level documentation as starting points for compound identification, while keeping unpegylated MGF separate from PEG-MGF in inventory records, analytical review, and internal study design.

Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:

• Mills et al. (2007) — Exp Cell Res
• Kandalla et al. (2011) — Mech Ageing Dev
• Tang et al. (2017) — Mol Brain

Storage, Handling & Stability Guidelines

The provided storage guidance is specific to the lyophilized material: store MGF at -20°C, desiccated, and protected from light. Those are the only compound-specific storage conditions supplied in the current source record.

After reconstitution, the source data instructs laboratories to aliquot the material and avoid repeated freeze-thaw cycles. The record does not provide a reconstitution solvent, target concentration, sterile-filtration requirement, post-reconstitution hold time, or validated stability window, so this page does not supply those values. Laboratories should establish any additional handling parameters through validated internal procedures and applicable lot-specific documentation.

• Keep lyophilized MGF sealed, desiccated, and protected from light during storage.
• Use -20°C storage for unreconstituted material unless current lot documentation specifies otherwise.
• After reconstitution, aliquot according to laboratory workflow to limit repeated freeze-thaw exposure.
• Maintain traceability between source vial, aliquot label, handling date, and operator records.
• Use appropriate personal protective equipment and institutional chemical-safety procedures for research peptides.

Lab Verification

Nexus maintains research-compound verification records through the Lab Verified archive. In general terms, HPLC verification may be used to review chromatographic profile and purity-related characteristics, while Mass Spectrometry verification may be used to support molecular-identity confirmation where current lot documentation is available.

No exact MGF COA values are included in the current product record. This page therefore does not list a batch number, purity percentage, HPLC retention time, observed mass, release date, analyst record, salt form, or counter-ion. For MGF, researchers should treat /lab-verified, product labeling, and current lot-specific documentation as the controlling sources for any batch-level analytical details.